- Report
- September 2022
- 51 Pages
Global
From €3595EUR$3,950USD£3,082GBP
- Report
- September 2022
- 103 Pages
Global
From €6826EUR$7,500USD£5,852GBP
- Report
- January 2022
- 60 Pages
Global
From €3595EUR$3,950USD£3,082GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1138EUR$1,250USD£975GBP
Necrobiosis Lipoidica (NL) is a rare skin disorder that affects the lower legs and is characterized by yellow-brown plaques with a waxy surface. It is a chronic, progressive disorder that can cause pain, itching, and ulceration. Treatment of NL is typically with topical corticosteroids, systemic corticosteroids, or immunosuppressants. Dermatological drugs are used to treat a variety of skin conditions, including NL.
The NL drug market is composed of a variety of products, including topical corticosteroids, systemic corticosteroids, and immunosuppressants. These drugs are used to reduce inflammation, reduce itching, and prevent ulceration. Additionally, some products are used to reduce the risk of infection and to promote healing.
Some companies in the NL drug market include GlaxoSmithKline, Pfizer, Merck, and Novartis. Show Less Read more